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Introduction {#sec1}
============

Brain development is a dynamic, complex, and well-organized process that initiates during the third gestational week and continues throughout development until late adolescence. During this period, neuronal differentiation, maturation, and migration are controlled and tightly regulated by carefully coordinated genetic programs ([@bib35]). Small changes in cellular environment and metabolic demands affect cellular fate and are often a requirement for correct neuronal maturation ([@bib22]). Even subtle disturbances during any of these processes can result in a number of neurodegenerative disorders, but the complexity of the brain and cellular metabolism has limited our understanding of neuronal homeostasis in health and disease. A small subgroup of neurodegenerative diseases is caused by inborn errors of metabolism (IEM), defined by the toxic accumulation of metabolic intermediates or the lack of vital substrates. IEM are caused by single gene defects, thus affecting specific biochemical pathways, such as carbohydrate, lipid, amino acid, lysosomal, mitochondrial, and peroxisomal metabolism ([@bib7]). The molecular and metabolic consequences observed in these diseases therefore offer unique opportunities to study the interplay between the genetic and the metabolic demands of the developing brain, providing vital advances in understanding the changes observed in more complex common neurodegenerative disorders.

We recently reported that the loss of the autophagy adaptor Sequestosome 1 (SQSTM1/p62) in nine individuals from four different families leads to a childhood- or adolescence-onset neurodegenerative disorder, characterized by progressive gait abnormalities, ataxia, dysarthria, dystonia, vertical gaze palsy, and cognitive decline ([@bib14]). Magnetic resonance imaging revealed atrophy of the cerebellum and the vermis cerebelli ([@bib14]). Eleven more patients, with similar clinical presentations, have since been reported ([@bib31]). Nevertheless, there was no clear indication of the pathogenetic mechanism leading to the clinical observations. p62 has been associated with several cellular processes, such as selective autophagy ([@bib26]) and mitophagy ([@bib37]), as well as responses to oxidative stress ([@bib19]), immune response ([@bib28]), and hypoxia ([@bib40]). More recently, p62 was also shown to be an important regulator in cancer metabolism, with increased p62 expression reported in lung ([@bib41]), liver, kidney, and breast cancers, as well as glioblastoma ([@bib52]). On the other hand, loss of p62 has also been suggested to promote prostate cancer progression by affecting the tumor\'s microenvironment ([@bib46]).

p62, thus, has been suggested to have both pleiotropic and tissue-specific roles, described in often contradictory reports. For instance, together with the E3-ubiquitin ligase PARKIN and the mitochondrial kinase PINK1, p62 has been widely proposed to regulate the maintenance and turnover of mitochondria by selective autophagy, also termed mitophagy ([@bib11]). Although the phenomenon of mitophagy under certain experimental conditions is generally accepted, its physiological role and mechanism are more controversial ([@bib13]), and several studies now dispute the involvement of p62 in this process ([@bib32], [@bib34]). Likewise, p62 has been proposed to stabilize nuclear factor erythroid 2-related factor 2 (NRF2) transcription factor under oxidative stress conditions, by preventing its KEAP1-mediated degradation and thereby triggering an oxidative stress gene expression response ([@bib3], [@bib9], [@bib17], [@bib24], [@bib27]). However, p62^−/−^ mice were still able to activate NRF2-induced gene responses ([@bib25]) and no changes in NRF2 and KEAP1 were observed in the absence of p62 in a pancreatic tumor model ([@bib46]).

To understand the disease mechanisms associated with the loss of p62, we studied the cellular and metabolic consequences in neuronal stem cells and neurons, derived from reprogrammed patient fibroblasts, as well as CRISPR/Cas9-targeted neuroepithelial stem cells (NESCs). Our data suggest that p62 is required for normal neurogenesis by controlling the expression of proteins involved in the metabolic shift from aerobic glycolysis to oxidative phosphorylation (OXPHOS) and protecting from oxidative stress. In particular, lactate dehydrogenase A (LDHA), a protein essential for this shift ([@bib53]), is upregulated and remains high in p62-knockout cells upon neuronal differentiation.

Results {#sec2}
=======

p62 Is Essential for Neuronal Differentiation {#sec2.1}
---------------------------------------------

In humans, loss of p62 leads to a childhood-onset neurodegenerative disease with no organs affected other than the central nervous system ([@bib14], [@bib31]). We therefore sought to study the role of p62 and reprogrammed fibroblasts from two patients carrying a nonsense mutation at the 5′ end of SQSTM1 (p.Arg96^∗^, patients II:1 and II:4 from family 4 in [@bib14]) to induced pluripotent stem cells (iPSCs), before differentiating them further to neuroepithelial-like stem cells (Pat1^NES^ or Pat2^NES^) (for details see [Experimental Procedures](#sec4){ref-type="sec"} and [@bib8], [@bib23]). NESCs exhibit an extensive proliferative lifespan and display a high differentiation potential to various neuronal subtypes and glial cells, allowing for a cell-type and patient-specific characterization ([@bib8], [@bib23]). We confirmed the NESC status of Pat1&2^NES^ cells by immunofluorescence and western blot of Nestin, SOX2, PLZF, and DACH1 ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). To control for potential effects due to differences in genetic background between Pat1&2^NES^ cells and control NESCs, we additionally applied CRISPR/Cas9 gene editing technology to control NESCs, targeting the 5′ terminus of SQSTM1, followed by clonal selection. Loss of p62 was confirmed by western blot and qPCR analysis ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}C). Two clones with confirmed loss of p62 were chosen as p62-knockout (KO) NESCs (KO1^NES^ and KO2^NES^), while two clones that retained normal p62 levels were used as CRISPR control (CCo1^NES^ and CCo2^NES^) cells (see [Experimental Procedures](#sec4){ref-type="sec"} for details).Figure 1p62 Is Essential for Neuronal Differentiation(A--C) (A) Representative western blot analysis of p62 in (top) Co1^NES^, Pat1^NES^, and Pat2^NES^ cells and (bottom) CCo1^NES^, KO1^NES^, KO2^NES^, and Pat1^NES^ cells. Tubulin was used as a loading control. n = 3 (n is defined as independent experiments). (B and C) Representative fluorescence images of Co1^NEU^ and Pat1^NEU^ after (B) 6 days differentiation, immunostained against α-tubulin (red) and DAPI (blue) (scale bar, 50 μm; n = 5), or (C) 20 days differentiation, immunostained against neurofilament (green), MAP2A/B (red), and DAPI (blue) or against β-III tubulin (green), HuC/D (red), and DAPI (blue) (scale bar, 100 μm; n = 5).(D--F) Thirty neuronal bodies of Co1^NEU^ (black), Co2^NEU^ (white), and Co3^NEU^ (gray) (pooled under the name Co^NEU^); Pat1^NEU^ (red); Pat1^NEU^ + p62 (brown); KO1^NEU^ (yellow); and Pat2^NEU^ (orange) were analyzed for (D) neuronal body area, (E) number of neuronal processes per neuronal body, and (F) width of neuronal processes. Data are expressed as mean ± SD and differences were tested by a two-tailed t test. ^∗∗∗^p \< 0.001, ^∗∗^p \< 0.01; n = 3.(G) Linear Sholl analysis representation of 20-days-differentiated control neurons (pooled data from Co1^NEU^, Co2^NEU^, and Co3^NEU^, under the name Co^NEU^, dark gray); Pat1^NEU^ (red); and Pat2^NEU^ (orange). n = 3. Neuronal processes were analyzed from 15 neuronal bodies per line.(H) Representative western blot analysis of steady-state levels of MAP2A/B, β-III tubulin, HuC/D, SOX2, and p62 in CCo1^NES^ and KO1^NES^ cells undifferentiated and after 14 or 50 days of differentiation. GAPDH was used as a loading control. n = 3.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

Removal of epidermal growth factor and basic fibroblast growth factor from the growth medium induces NESCs to arrest their cell cycle and undergo genomic reprogramming for neuronal differentiation toward neuronal and glial phenotypes. Early steps of this differentiation are marked by the appearance of 1- to 2-μm-thin projections, termed neuronal processes, which will fuse and build a complex network of connected mature neurons with prolonged differentiation. After 6 days of differentiation, control NESCs (Co^NEU^) presented with the expected formation of neuronal processes, as observed by immunocytochemistry against α-tubulin. In contrast, patient NESCs (Pat1^NEU^) showed a marked decrease in the formation of these neuronal processes ([Figure 1](#fig1){ref-type="fig"}B). After 20 days of differentiation, when morphological maturation of neurons is almost completed, control cells showed a clear organizational structure of thick neuronal processes, while patient-derived neurons showed an aberrant and disorganized morphology along with morphologically undifferentiated cells ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}D--S1F). Immunostaining, using the neuronal markers Neurofilament, MAP2A/B, HuC/D, and β-III tubulin with subsequent quantification, showed a mild reduction in neuronal body area and a clear reduction in the number and width of mature neuronal processes emerging from these neuronal bodies ([Figures 1](#fig1){ref-type="fig"}D--1F). Sholl analysis ([@bib43]) demonstrated that patient cells develop interactions within the nearby cell cluster but are unable to connect with more distant cells, having shorter extensions than control cells ([Figure 1](#fig1){ref-type="fig"}G) (individual Sholl analyses of the control cells are shown in [Figure S1](#mmc1){ref-type="supplementary-material"}G). This deviant neuronal differentiation could also be observed in CRISPR/Cas9 gene-editing-derived KO^NES^ cells ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B), as well as in control NESCs, where p62 expression was silenced by short hairpin RNA ([Figure S2](#mmc1){ref-type="supplementary-material"}C). Exogenous expression of wild-type p62 in Pat1^NES^ cells reversed this deficiency ([Figures 1](#fig1){ref-type="fig"}D--1F and [S2](#mmc1){ref-type="supplementary-material"}D). Western blot analysis of the neuronal markers β-III tubulin, HuC/D, and MAP2A/B, as well as the stem cell marker SOX2, confirmed that, while control cells were able to undergo neuronal differentiation, cells lacking p62 exhibited a general decrease in the expression of neuronal markers and retained a high degree of stemness, even after 45 days of differentiation ([Figure 1](#fig1){ref-type="fig"}H). Elevated levels of SOX2 protein in patient neurons after 25 and 45 days of differentiation were confirmed by immunostaining ([Figure S2](#mmc1){ref-type="supplementary-material"}E). Together, our data show that p62 is required for the formation of neuronal processes and the differentiation into neurons.

Loss of p62 in NESCs Results in Reduced Respiratory Chain Function {#sec2.2}
------------------------------------------------------------------

Mitochondrial function has recently been shown to be required for neuronal differentiation ([@bib21]), and we therefore compared mitochondrial respiratory chain function of NES control cells and NESCs lacking p62. In agreement with skeletal muscle and fibroblast samples ([@bib14]), Pat1&2^NES^ cells had a mild reduction in respiratory chain enzyme activities of complexes I and IV ([Figure 2](#fig2){ref-type="fig"}A), with reduced basal respiration capacity ([Figure 2](#fig2){ref-type="fig"}B), but normal mitochondrial ATP production rates ([Figure 2](#fig2){ref-type="fig"}C).Figure 2Loss of p62 in NESCs Results in Reduced Respiratory Chain Function, but p62 Is Dispensable for Mitophagy(A) Mitochondrial respiratory chain enzyme activities in Co1^NES^ (black), Co2^NES^ (white), Pat1^NES^ (red), and Pat2^NES^ (orange). Complex I (CI; NADH coenzyme Q reductase), complex I + III (CI+III; NADH cytochrome *c* reductase), complex II (CII; succinate dehydrogenase), complex II + III (CII+III; succinate cytochrome *c* reductase), and complex IV (CIV; cytochrome *c* oxidase) are shown. Data are presented as mean ± SD and differences were tested by a two-tailed t -test. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, n = 3.(B) Oxygen consumption rates from Co1^NES^ (black), Co2^NES^ (white), Pat1^NES^ (red), and Pat2^NES^ (orange), treated with CCCP or dinitrophenol (DNP). Data are expressed as mean ± SD and differences were tested by a two-tailed t test. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, n = 3.(C) Mitochondrial ATP production rates in Co1^NES^ (gray) and Pat1^NES^ (red) supplemented with glutamate/succinate (Glu+Succ), pyruvate/L-malate (Pyr+Mal), or palmitoylcarnitine/L-malate (PalCar+Mal). Data are expressed as units per unit of citrate synthase (CS).(D) Representative confocal images of control fibroblasts transfected with YFP-Parkin (green) and treated with CCCP (20 μM) (top) or O/A (10 μM/1 μM) (bottom) for 2 h. Fibroblasts were immunostained against Tom20 (red) and p62 (blue). n = 3.(E) Representative confocal images of Co1^NES^ cells treated for 2 h with or without 10 μM CCCP or O/A (5 μM/1 μM) and with or without 50 nM bafilomycin, using antibodies against p62 (green) and TOM20 (red) and DAPI stain (blue). Scale bar: 20 μm. n = 3.(F) Representative confocal images of 14-days-differentiated neurons treated for 2 h with or without 10 μM CCCP or O/A (5 μM/1 μM) and with or without 50 nM bafilomycin, using antibodies against p62 (green) and TOM20 (red) and DAPI staining (blue). Scale bar: 20 μm. n = 3.(G and H) Representative western blot analysis of (G) Co1^NES^ and Pat1^NES^ cells treated for 12 h or (H) Co1^NEU^ and Pat1^NEU^ after 20 days of differentiation treated for 2 h with or without 10 μM CCCP or O/A (5 μM/1 μM) and with or without 50 nM bafilomycin for 2 h. n = 3.See also [Figures S2--S4](#mmc1){ref-type="supplementary-material"} and [Table S2](#mmc1){ref-type="supplementary-material"} for p62 primers.

An attractive explanation for the reduced respiratory chain function could be a decreased capacity of the cells to remove damaged mitochondria, since p62, together with the E3-ubiquitin ligase PARKIN and the mitochondrial kinase PINK1, has been reported to be important for this process ([@bib37]). Human fibroblasts express low levels of endogenous PARKIN and thus, as previously shown, only the exogenous overexpression of YFP-PARKIN showed the typical co-localization between the mitochondrial outer membrane protein TOM20 and p62 upon treatment with the mitochondrial uncoupler carbonyl cyanide m-chlorophenyl hydrazone (CCCP) or with the mitochondrial complex inhibitors oligomycin and antimycin (O/A) ([Figures 2](#fig2){ref-type="fig"}D, [S2](#mmc1){ref-type="supplementary-material"}F, and S2G). In contrast, both NESCs and NESCs undergoing neuronal differentiation (14-day neurons) express high levels of endogenous PARKIN and the absence of p62 should therefore have an impact on mitochondrial clearance upon depolarization ([Figure S2](#mmc1){ref-type="supplementary-material"}H). However, both cell types showed very little co-localization of p62 with TOM20 with or without the addition of bafilomycin, an inhibitor of the lysosomal proton pump that blocks lysosomal function ([Figures 2](#fig2){ref-type="fig"}E, 2F, and [S2](#mmc1){ref-type="supplementary-material"}G). Furthermore, fibroblasts ([Figure S2](#mmc1){ref-type="supplementary-material"}I), NESCs ([Figure 2](#fig2){ref-type="fig"}G), and differentiated neurons ([Figure 2](#fig2){ref-type="fig"}H) lacking p62 showed the expected LC3II and PINK1 levels upon CCCP or O/A treatment, suggesting that autophagosome formation and PINK1 stabilization, two classical features of mitophagy, were activated even in the absence of p62. Induction of mitophagy by mitochondrial toxins is associated with the loss of mitochondrial markers ([@bib33]); however, we observed only a mild reduction of mitochondrial proteins in control and patient fibroblasts, which could be reversed with bafilomycin ([Figures S2](#mmc1){ref-type="supplementary-material"}J and S2K), and no reduction in NESCs ([Figure 2](#fig2){ref-type="fig"}G) and neurons ([Figure 2](#fig2){ref-type="fig"}H). Co-localization of the autophagosomal marker LC3II or lysosomal marker LAMP2 with the mitochondrial marker TOM20 was not affected in fibroblasts ([Figures S2](#mmc1){ref-type="supplementary-material"}L and S2M), NESCs ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B), or differentiated neurons ([Figures S4](#mmc1){ref-type="supplementary-material"}A and [S3](#mmc1){ref-type="supplementary-material"}B) upon loss of p62. Together, these results demonstrate that p62 is not required for the autophagocytic removal of mitochondria upon mitochondrial depolarization in cells with endogenous expression of PARKIN. It also suggests that the observed neuronal phenotypes caused by the loss of p62 are not associated with deficient mitophagy.

Compromised Neuronal Differentiation Can Be Partly Rescued by N-Acetyl-L-cysteine {#sec2.3}
---------------------------------------------------------------------------------

Oxidative stress and the regulation of reactive oxygen species (ROS) levels have previously been shown to have an important role during neuronal differentiation ([@bib48]). Mitochondria are the main source of intracellular ROS and a mild mitochondrial defect can lead to increased levels of ROS. Moreover, p62 has been suggested to regulate NRF2, previously shown to regulate genes containing antioxidant response elements (AREs) via KEAP1 ([@bib19]). KEAP1 degrades NRF2 and thus the loss of p62 would deregulate the KEAP1-NRF2-ARE pathway ([@bib24]) and increase sensitivity to oxidative stress ([@bib36]). Although patient NESCs undergoing neuronal differentiation did not have increased ROS levels, KO1^NEU^ cells showed a marked increase after 4 days differentiation ([Figures 3](#fig3){ref-type="fig"}A and 3B), consistent with the more severe phenotype. In addition, glutathione levels were reduced in the absence of p62 ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Furthermore, NESCs lacking p62 were more sensitive to CCCP treatment in comparison with control cells ([Figure 3](#fig3){ref-type="fig"}C). Supplementing growth conditions with the antioxidant N-acetyl-L-cysteine (NAC) allowed p62-deficient NESCs to partially regain their differentiation potential, as indicated by reduced cell death ([Figures 3](#fig3){ref-type="fig"}C and 3D) as well as increased axonal projections ([Figure 3](#fig3){ref-type="fig"}E), suggesting an important role of p62 in the cellular oxidative stress response. However, we observed no differential response between control cells and cells lacking p62 treated with CCCP in KEAP1 levels ([Figure 3](#fig3){ref-type="fig"}F) and antioxidant genes *NRF2*, γ-glutamylcysteine synthetase (*GCLM*), and the calcium channel blocker resistance protein (*CCBRP*, also known as *xCT* or *SLC7A11*) ([Figures 3](#fig3){ref-type="fig"}G and [S4](#mmc1){ref-type="supplementary-material"}D). Interestingly, p62 protein, mRNA expression levels, and subcellular redistribution to a more punctuated pattern increased in control cells after CCCP and O/A treatment ([Figures 2](#fig2){ref-type="fig"}G, [3](#fig3){ref-type="fig"}H, and [S4](#mmc1){ref-type="supplementary-material"}E), suggesting a role of p62 in the antioxidant response. Accordingly, NAC treatment prevented the increase of the antioxidant genes *xCT*, *NRF2*, *GCLM*, and *p62* ([Figures 3](#fig3){ref-type="fig"}H and 3I). In agreement with increased oxidative stress, several key mitochondrial antioxidant enzymes, such as *GPX1*, *GPX4*, *NQO1*, *GSTM4*, and *GSTP1*, were differentially expressed in cells lacking p62 ([Figures 3](#fig3){ref-type="fig"}J, 3K, [S4](#mmc1){ref-type="supplementary-material"}F, and S4G), supporting the notion that p62 is essential in protecting neuronal progenitor cells from oxidative damage, independent of the KEAP1-NRF2-ARE pathway.Figure 3Compromised Neuronal Differentiation due to Deficient p62 Can Be Rescued by NAC(A) Quantification of the average CM-H~2~DCFDA signal in four control NESCs (Co1^NEU^, Co2^NEU^, Co3^NEU^, CCo1^NEU^ \[pooled as Co^NEU^\]), Pat1^NES^, Pat2^NES^, and KO1^NES^.(B) As in (A), but on cells after 4 days of differentiation. Data are expressed as mean ± SD and differences were tested by a two-tailed t test. ^∗^p \< 0.05, ^∗∗^p \< 0.01; n = 3 with 50 cells analyzed per experiment.(C) Cell viability assay of CCo1^NES^, Co1^NES^, Co2^NES^, and Co3^NES^ (dark gray, pooled as Co^NES^), Pat1^NES^ (red), and Pat2^NES^ (orange) after a 15-h treatment with 20 μM CCCP or 20 μM CCCP and 1 mM NAC as indicated. Data are presented as mean ± SD and differences were tested by a two-tailed t test. ^∗∗^p \< 0.01 and ^∗∗∗^p \< 0.001, n = 3.(D) Representative bright-field images of Co1^NES^ and Pat1^NES^ cells, treated for 15 h with 20 μM CCCP or 20 μM CCCP +1 mM NAC. Scale bar, 100 μm; n = 3.(E) Representative bright-field images of KO1^NES^ (±1 mM NAC) subjected to differentiation for 6 or 14 days. Scale bar, 100 μm; n = 3.(F) Representative western blot analysis of Nrf2, KEAP1, and p62 in Co1^NES^ and Pat1^NES^ cells untreated and treated for 12 h with 10 μM CCCP or 10 μM oligomycin and 1 μM antimycin (O/A) as indicated. Tubulin was used as a loading control. n = 3.(G--I) qRT-PCR analysis in Co1^NES^ (black) and Pat1^NES^ (red) cells, treated (striped) or untreated (solid) for 6 h with 10 μM CCCP and/or 1 mM NAC as indicated for (G) *NRF2*, *GCLM*, and *xCT* (left) and *GSS*, *NQO1*, and *GSTM4* (right) (n = 4); (H) *p62* (n = 3); or (I) *NRF2*, *GCLM*, and *xCT* (n = 3). β-actin was used as an endogenous control. Data are expressed as mean ± SD and differences were tested by a two-tailed t test. ^∗^p \< 0.05 and ^∗∗^p \< 0.01.(J and K) qRT-PCR analysis of CCo1^NES^ (gray), KO1^NES^ (yellow), and Pat1^NES^ (red) cells for (J) *GPX1*, *GPX4*, *GSTK1*, *GSTA1*, and *GSTP1* or (K) *NQO1* and *GSTM4* steady-state levels. β-actin was used as an endogenous control. Data are expressed as mean ± SD and differences were tested by a two-tailed t test. ^∗^p \< 0.05, ^∗∗^p \< 0.01, n = 3. See also [Figure S4](#mmc1){ref-type="supplementary-material"} and [Table S2](#mmc1){ref-type="supplementary-material"} for primers used.

p62 Regulates Gene Expression Changes Involved in the Metabolic Switch Occurring during Neuronal Differentiation {#sec2.4}
----------------------------------------------------------------------------------------------------------------

To identify additional pathways affected by the absence of p62, we studied changes in the global gene expression patterns of NESCs during 4 days of differentiation in the presence or absence of p62. To ensure equal genetic background and stemness status of the NESCs prior to differentiation, we chose to use CRISPR/Cas9-derived KO (KO^NES^) and control (CCo^NES^) cells. Neuronal development is associated with changes in the expression of several neuronal markers, and as expected, the neuronal markers Pax6, NeuroG1, NeuroD1, and NeuroD2 were upregulated in control cells 4 days after the induction of neuronal differentiation ([Table S1](#mmc2){ref-type="supplementary-material"}). Furthermore, we used WebGestalt to perform gene set enrichment analysis (GSEA) to cluster genes according to gene ontology terms related to biological function, molecular process, or cellular component ([@bib50]). Transcriptomic data revealed a positive enrichment of "central nervous system neuron differentiation" and "neurotransmitter receptor activity" ([Figure 4](#fig4){ref-type="fig"}A). A comparison of the 500 most significant genes against the Human Gene Atlas with EnrichR presented fetal brain as the tissue with the most similar gene expression profile (q = 0.002). These data indicate that our neuronal differentiation model indeed represents stages of neuronal development.Figure 4p62 Is Essential for the Metabolic Switch Required during Neuronal Differentiation(A) Gene ontology (GO) analysis comparing gene expression profiles of CCo1^NES^ and CCo2^NES^ cells after 0 and 4 days of differentiation.(B) Transcriptomic profiling of CCo1^NES^, CCo2^NES^, KO1^NES^, and KO2^NES^ cells during differentiation. Venn diagram showing the number of significantly differentially expressed genes at p \< 0.01 in CCo1^NES^, CCo2^NES^, KO1^NES^, and KO2^NES^ cells during differentiation.(C) Log2-fold changes of transcripts during differentiation of control CCo1^NES^ and CCo2^NES^ cells against KO1^NES^ and KO2^NES^ cells. In blue is the fitted regression line of a linear model, in gray the 45° line.(D) Gene set enrichment analysis of RNA sequencing data against four different databases. The dotted line indicates a false discovery rate (FDR) of 0.01.(E) Comparison of gene expression fold changes of OXPHOS-related gene sets, annotated in three databases, in CCo and KO cells after 4 days differentiation. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, calculated using Welch\'s t test. Boxplot outlines depict lower and upper quartile and median.See also [Figure S5](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc2){ref-type="supplementary-material"}.

Comparison of differential expression patterns during 4 days of NESC differentiation between p62-KO and control cells identified 964 and 162 unique differentially expressed genes in CCo^NES^ or KO^NES^ cells at α = 0.01, respectively ([Figures 4](#fig4){ref-type="fig"}B and 4C, [Table S1](#mmc2){ref-type="supplementary-material"}). The expression changes of 120 genes were common between the two genotypes, suggesting that these genes are not related to p62 function. KO^NES^ cells had a milder gene response to differentiation, with genes associated with neuronal differentiation induced only in control NESCs ([Table S1](#mmc2){ref-type="supplementary-material"}), corroborating the neuronal differentiation defect observed due to the absence of p62. A pathway-based GSEA revealed a positive enrichment for apoptotic pathways, which is an imprint of increased death of KO^NES^ cells under differentiation ([Figure 4](#fig4){ref-type="fig"}D). Recent work from Zheng and colleagues suggests that neuronal progenitor cells initiate a metabolic shift from glycolytic to a more OXPHOS metabolism during differentiation ([@bib53]). In agreement, OXPHOS-related genes increased in control NESCs undergoing differentiation ([Figure 4](#fig4){ref-type="fig"}E). However, KO^NES^ cells had a significantly lower expression of OXPHOS genes, with a median log2-fold change around 0, thus showing that the loss of p62 prevents NESCs from reprogramming their energy metabolism ([Figure 4](#fig4){ref-type="fig"}E).

Loss of p62 Alters Cellular Energy Metabolism {#sec2.5}
---------------------------------------------

We argued that the loss of p62 altered the intracellular environment already in NESCs, preventing them from fully committing to neuronal differentiation. We therefore compared transcriptomic ([Figure 5](#fig5){ref-type="fig"}A) and proteomic ([Figure 5](#fig5){ref-type="fig"}B) expression profiles of NESCs lacking p62 with those of control NESCs before differentiation. We found 695 differentially expressed transcripts (5.1% of all accepted transcripts) and 168 differentially expressed proteins (5.5%) at a false discovery rate of \<0.05 ([Figures 5](#fig5){ref-type="fig"}A and 5B and [Table S1](#mmc2){ref-type="supplementary-material"}). One of the most significant changes observed due to the loss of p62 was the profound upregulation of LDHA, an enzyme that catalyzes the conversion between pyruvate and lactate, in both the transcriptomic and the proteomic datasets ([Figures 5](#fig5){ref-type="fig"}A and 5B). We confirmed that this upregulation was a consequence of the loss of p62, as patient and KO cell lines showed the same response by western blotting ([Figure S5](#mmc1){ref-type="supplementary-material"}A) and qRT-PCR ([Figure S5](#mmc1){ref-type="supplementary-material"}B). Interestingly, LDHA levels did not change in control NESCs after 4 days differentiation, while they slightly decreased in the absence of p62, on both protein and transcript levels ([Figures 5](#fig5){ref-type="fig"}D and 5E). To our surprise, though, fibroblasts obtained from both patients who were the initial source for the generation of the Pat1 and Pat2 NESCs did not show this increase ([Figure S5](#mmc1){ref-type="supplementary-material"}C), suggesting that this LDHA induction is a tissue-specific response. GSEA against four different pathway libraries further revealed that loss of p62 leads to increased expression of several gene groups involved in pyruvate metabolism and pyruvate dehydrogenase (PDH) regulation ([Figures 5](#fig5){ref-type="fig"}A--5C). For instance, the PDH complex was negatively regulated via its inhibitor PDH kinase 3 (PDK3), while the PDH phosphorylase (PDP) was inhibited via the PDP regulatory subunit (PDPR). In addition, gluconeogenesis and fatty acid biosynthesis were downregulated, as reflected by the transcript levels of phosphoenolpyruvate carboxykinase 2 (PCK2) and malic enzymes (ME) 1 and 3, respectively ([Figure 5](#fig5){ref-type="fig"}F). Amino acid metabolic pathways appeared upregulated in the absence of p62, probably as a consequence of a dysregulation in pyruvate metabolism ([Figure 5](#fig5){ref-type="fig"}C).Figure 5Loss of p62 Alters Cellular Energy Metabolism(A) High-throughput data analysis of CCo1^NES^, CCo2^NES^, KO1^NES^, and KO2^NES^ cells before differentiation. Volcano plot of differentially transcribed genes, identified by RNA sequencing (n = 13,601 after filtering). FDR, false discovery rate.(B) Volcano plot of differentially expressed proteins identified by proteomics (n = 3,058 after filtering).(C) Gene set enrichment analysis of RNA sequencing data against proteomics analysis. Blue- and orange-colored areas indicate increasing confidence.(D) Representative western blot analysis of LDHA and HK2 in Co1^NEU^ and Pat1^NEU^ after 0, 2, or 4 days of differentiation. Tubulin was used as a loading control. n = 3.(E) qRT-PCR analysis of *LDHA* steady-state levels in Co1^NEU^ (dark gray) and Pat1^NEU^ (red) cells after 0 or 4 days of differentiation. β-actin was used as an endogenous control. n = 3.(F) Expression levels of enzymes involved in pyruvate metabolism in undifferentiated KO1&2^NES^ cells compared with undifferentiated CCo1&2^NES^ cells. Left square of mini-heatmaps, transcriptome; right square, proteome; black dot, data not captured.(G) Representative western blot analysis of Thr389 phosphorylation of P706SK in Co1^NES^ and Pat1^NES^ cells. Tubulin was used as a loading control. n = 3.(H) Representative western blot analysis of Myc steady-state levels in CCo1^NES^, Pat1^NES^, and KO1^NES^ cells. Tubulin was used as a loading control. n = 3.See also [Figure S5](#mmc1){ref-type="supplementary-material"} and [Table S2](#mmc1){ref-type="supplementary-material"} for LDHA primers.

LDHA is a key regulator of anaerobic metabolism and its expression is regulated by the Phosphatidylinositol 3-kinase/Akt/Mammalian target of rapamycin (PI3K/Akt/mTOR) pathway, among others ([@bib47], [@bib51]). Previous work suggests that p62 regulates mTORC1 pathway activation ([@bib5]), leading to the stabilization of the v-Myc avian myelocytomatosis viral oncogene homolog (c-Myc), an important transcription factor involved in cell cycle progression, apoptosis, cellular transformation, cancer progression ([@bib46]), and neuronal differentiation ([@bib16]). In agreement, loss of p62 resulted in reduced mTOR activation, as indicated by phosphorylation of Thr389 of P70S6K ([Figure 5](#fig5){ref-type="fig"}G), and reduced expression of the LAMTOR proteins LAMTOR1, LAMTOR3, and LAMTOR5 ([Figures 5](#fig5){ref-type="fig"}B and 5C). As expected, c-Myc protein levels were reduced in the absence of p62, suggesting reduced mTOR activation ([Figure 5](#fig5){ref-type="fig"}H). In stark contrast, transcripts of c-Myc targets, such as genes associated with glucose metabolism (*LDHA*), DNA replication (*MCM2*, *MCM6*), or proteasomal function (*PSMA4*, *PSMA7*), were upregulated ([Figures 5](#fig5){ref-type="fig"}A--5C), indicating differential gene regulation of c-Myc targets upon loss of p62. Interestingly, the pro-glycolytic modulator hexokinase 2 (HK2) was elevated in NESCs lacking p62, and only slightly reduced during 4 days of differentiation, while it was completely downregulated in control cells ([Figure 5](#fig5){ref-type="fig"}D and [Table S1](#mmc2){ref-type="supplementary-material"}), further supporting the notion of a dysregulated energy metabolism.

Physiological Oxygen Concentrations Reveal a Pro-glycolytic Metabolism in the Absence of p62 {#sec2.6}
--------------------------------------------------------------------------------------------

As described, the increased levels of LDHA could not be explained by c-Myc activation. Exposing mice or cultured cells to oxygen concentrations lower than normoxia (20% oxygen concentration) triggers the activation of anaerobic glycolysis and diminishes mitochondrial aerobic metabolism ([@bib18]). Moreover, transcription of LDHA and other glycolytic genes is activated by Hif-1α under hypoxic conditions ([@bib4]). Results in cancer cells exposed to strict hypoxia (≤1% oxygen concentration) showed hypoxia-activated macroautophagic removal of p62 ([@bib38]) and p62 regulation of PHD3 activity ([@bib40]). Compared with controls, KO1&2^NES^ presented higher levels of LDHA, HK2, and PDK3, a typical pro-glycolytic gene expression profile, already in normoxia, and we therefore hypothesized that p62-deficient NESCs assume a constant hypoxic state when cultured in normoxia. Exposure to physiological oxygen levels would then even further aggravate the abnormal gene expression profile. The exact *in vivo* oxygen pressure of a tissue is difficult to determine, and we decided to incubate NESCs at 3% oxygen concentration. As previously reported ([@bib30]), Hif-1α expression was low and almost undetectable in control cells in normoxia, but increased profoundly after several hours in hypoxia, before decreasing again after 24 h ([Figures 6](#fig6){ref-type="fig"}A, 6B, [S6](#mmc1){ref-type="supplementary-material"}A, and S6B). Hif-1α levels also responded to low oxygen concentrations in NESCs lacking p62 and even remained elevated after 24 h, compared with control NESCs ([Figures 6](#fig6){ref-type="fig"}A, 6B, [S6](#mmc1){ref-type="supplementary-material"}A, and S6B). As expected, other factors, such as HK2, PDK1, and PDK3, also had a mild induction under these conditions, while LDHA levels remained increased in patient NESCs ([Figures 6](#fig6){ref-type="fig"}C and [S6](#mmc1){ref-type="supplementary-material"}C). We confirmed the induction of Hif-1α by treating NESCs with CoCl~2~, known to mimic hypoxia ([@bib29]), demonstrating that even in the absence of p62, NESCs responded to hypoxic conditions ([Figures 6](#fig6){ref-type="fig"}D and [S6](#mmc1){ref-type="supplementary-material"}D), suggesting that the pronounced pro-glycolytic profile observed in these cells is independent of Hif-1α.Figure 6Physiological Oxygen Concentrations Reveal a Pro-glycolytic Metabolism in the Absence of p62(A) Representative western blot analysis of Hif-1α and p62 steady-state levels in Co1^NES^ and Pat1^NES^ cells, cultured for 0, 8, or 24 h at 3% O~2~. Tubulin was used as a loading control (n = 3).(B) Quantification of (A). Data are expressed as mean ± SD and differences were tested by a two-tailed t test. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, n = 3.(C) Western blot analysis of HK2, PDK1, PDK3, and LDHA as in (A). Tubulin was used as a loading control. n = 3.(D) Western blot analysis of Hif-1α expression in Co1^NES^ and Pat1^NES^ cells, cultured for 0, 5, or 24 h in the presence of 200 μM CoCl~2~. Tubulin was used as loading control. n = 5.See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

More than 130 million people are predicted to suffer from some form of dementia by 2050. With an increasing aging population, neurodegenerative disorders have already become a major burden, not only to the affected. Given the urgency of understanding these diseases, surprisingly few treatment options are available. The importance of particular metabolic networks is increasingly being recognized in disease progression, but studying their interplay has been more difficult. We decided to investigate the molecular consequences of a monogenic neurodegenerative disorder in a brain-appropriate model. The autophagy adaptor protein SQSTM1/p62 has been associated with a number of different functions, including as adaptor for mitochondrial clearance. This association stems from observations made in immortalized cell lines, exogenously overexpressing several components of the proposed process, such as PARKIN or LC3 ([@bib37]). We could not confirm this commonly assumed association between p62 and mitophagy in NESCs or neurons, which naturally express high levels of PARKIN.

In contrast, our data indicate that p62 is required for neuronal progenitor cells to change their metabolic microenvironment to a more oxidative metabolism, necessary for neurodifferentiation. Neuronal development is a metabolically dynamic process, during which the interconnection between aerobic glycolysis and OXPHOS is crucial for proper differentiation ([@bib1]). We observed that the loss of p62 resulted in a significant upregulation of the glycolytic regulators LDHA and HK2 and the inability to promote OXPHOS gene expression. Downregulation of LDHA and HK2 is essential during neuronal differentiation and is blocked by exogenous expression of LDHA ([@bib53]). Induction of differentiation did lead to the expected decrease in LDHA and HK2 levels in the absence of p62, but levels remained high, suggesting that the initial levels were too high and/or that p62 is involved in their turnover. The consequences, however, are that although the cell is initiating some of the required steps for differentiation, the metabolic environment prevents their execution. Support comes from a recent observation of increased lactate in the ventricular cerebrospinal fluid of a patient with disrupted p62 ([@bib31]). Interestingly, the same study also disrupted p62 expression in a zebrafish model, and reported structural defects in the cerebellum, including reduced axonal connections and complete atrophy. These observations strongly support our observation that p62 is important for correct neuronal function. Several regulators of LDHA have been reported, including c-Myc and Hif-1α ([@bib47]), and numerous c-Myc targets were upregulated in the absence of p62, including LDHA, but c-Myc itself was downregulated, on both mRNA and protein levels, suggesting alternative transcriptional regulatory mechanisms of its targets. Hif-1α is recognized as the key regulator of systemic and cellular responses to low oxygen concentrations, and p62-KO cells grown under physiological oxygen levels revealed a pronounced Hif-1α stabilization, as well as increased expression of pro-glycolytic genes, such as *LDHA*, *HK2*, *PDK1*, or *PDK3*. However, in normoxia, where Hif-1α levels are similar, NESCs lacking p62 already present with increased LDHA levels, suggesting that p62 is required for Hif-1α-dependent downregulation during hypoxia but that another factor(s) must be involved in the upregulation of LDHA. Interestingly, fibroblasts from p62^−/−^ patients did not have increased LDHA levels. Recently, two oxygen-sensing cysteine residues in p62 were reported to be important during a p62-dependent autophagic stress response ([@bib2]), thus suggesting that p62 itself might have oxygen-sensing capacity. Our results indicate that under reduced oxidative stress, either due to reduced oxygen pressure or due to supplementation of antioxidant, neurodifferentiation is improved. Thus, p62 is important during certain stages of development or under stress conditions, which could explain both the normal neuronal development until childhood and the progressive nature of clinical presentation of patients with disrupted p62 ([@bib14], [@bib31]).

Although mature neurons are thought to primarily rely on OXPHOS for ATP synthesis ([@bib45]), a more glycolytic energy metabolism in the brain has been proposed during childhood ([@bib12]). Such a shift in preference could explain the timing of disease onset and the progressive nature of the clinical presentations in the patients with mutations in p62 ([@bib14], [@bib31]). The appearance of p62-positive aggregates in Purkinje cells in the cerebellum of old mice also points to an important role of p62 in the brain ([@bib2]). Increased demands on respiration could also increase oxidative stress, and NESCs lacking p62 displayed increased ROS formation during maximal respiration and differentiation, with several antioxidant pathways induced, including GPX1, GPX4, or ALDH1B1 and decreased levels of NQO1. Alterations in the cellular antioxidant response are in agreement with observations made in p62^−/−^ mice, which also showed reduced NQO1 levels and altered GSH/GSSG ratio ([@bib25]). Interestingly, NQO1^−/−^ mice showed an unbalanced redox status and accumulation of lactate and decreased glucose levels, suggesting a link between low NQO1 levels and glucose metabolism ([@bib10]). NRF2 is a key regulator of the antioxidant response and the KIR domain of p62 is thought to interact with the NRF2 regulator KEAP1. However, we found no dysfunctional KEAP1-NRF2-ARE pathway regulation upon deletion of p62 in NESCs, which is in agreement with results both in p62^−/−^ mice ([@bib25]) and in pancreatic tumor cells ([@bib46]).

p62-KO mice are viable ([@bib6], [@bib25]), but die prematurely ([@bib25]) and present with several neurological phenotypes, ranging from memory loss to behavioral abnormalities to the accumulation of Tau tangles ([@bib39]). The patients reported by us also had memory loss and elevated Tau levels ([@bib14]), demonstrating the similarities of the two systems. In addition, p62 was shown to be important for neuronal cell survival and development in rats ([@bib20]). However, p62 ablation rescues the neural stem cell pool in the subventricular zone and dental gyrus of FIP 200-KO mice at p28, suggesting the importance of p62 in the regulation of neuronal development ([@bib49]).

A carefully regulated metabolic environment is increasingly recognized as an important part of neuronal brain development ([@bib1], [@bib15], [@bib42], [@bib44]), and our data clearly show that p62 is required for the metabolic transition during neuronal differentiation.

In conclusion, our findings shed light on the pathogenetic mechanisms behind the childhood onset of ataxia, dystonia, and cognitive decline that result from loss of p62. Importantly, they also indicate that an active promotion of a metabolic shift from glycolysis to OXPHOS is required for neuronal survival beyond the early stages of brain development, and that an inability to promote this shift can lead to neurodegeneration.
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Detailed descriptions of experimental procedures can be found in the [Supplemental Information](#app2){ref-type="sec"}.

Ethical Considerations {#sec4.1}
----------------------

This study has been approved by the Regional Ethics Committee at Karolinska Institutet in Stockholm, Sweden. Informed consent was obtained from all individuals involved.

Cell Culture {#sec4.2}
------------

Human primary skin fibroblasts were reprogrammed to iPSCs and subsequently induced to NESCs as described in detail in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

CRiSPR/Cas9 Gene Editing {#sec4.3}
------------------------

Generation of p62-KO cell lines was performed as described in detail in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Transcriptomic and Proteomic Analysis {#sec4.4}
-------------------------------------

Samples were prepared and analyzed as described in detail in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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Further information and requests for resources and reagents should be directed to Anna Wredenberg (<anna.wredenberg@ki.se>).
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